BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Watanabe Y, Ohtsuka T, Matsunaga T, Kimura H, Tamura K, Ideno N, Aso T, Miyasaka Y, Ueda J, Takahata S, Igarashi H, Inoguchi T, Ito T, Tanaka M. Long-term outcomes after total pancreatectomy: special reference to survivors' living conditions and quality of life. World J Surg. 2015;39:1231-1239. [PMID: 25582768 DOI: 10.1007/s00268-015-2948-1] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 6.1] [Reference Citation Analysis]
Number Citing Articles
1 Suto H, Kamei K, Kato H, Misawa T, Unno M, Nitta H, Satoi S, Kawabata Y, Ohtsuka M, Rikiyama T, Sudo T, Matsumoto I, Hirao T, Okano K, Suzuki Y, Sata N, Isaji S, Sugiyama M, Takeyama Y. Risk factors associated with hypoglycemic events after total pancreatectomy: A nationwide multicenter prospective study in Japan. Surgery 2022:S0039-6060(22)00296-3. [PMID: 35820975 DOI: 10.1016/j.surg.2022.04.031] [Reference Citation Analysis]
2 Miyasaka Y, Nakamura M. Remnant Pancreatic Cancer After Surgical Resection for Pancreatic Cancer. The IASGO Textbook of Multi-Disciplinary Management of Hepato-Pancreato-Biliary Diseases 2022. [DOI: 10.1007/978-981-19-0063-1_54] [Reference Citation Analysis]
3 Shao W, Lu Z, Xu J, Shi X, Tan T, Xing C, Song J. Effects of Total Pancreatectomy on Survival of Patients With Pancreatic Ductal Adenocarcinoma: A Population-Based Study. Front Surg 2021;8:804785. [PMID: 34957210 DOI: 10.3389/fsurg.2021.804785] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Toms C, Steffens D, Yeo D, Pulitano C, Sandroussi C. Quality of Life Instruments and Trajectories After Pancreatic Cancer Resection: A Systematic Review. Pancreas 2021;50:1137-53. [PMID: 34714277 DOI: 10.1097/MPA.0000000000001896] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Téoule P, Tombers K, Rahbari M, Sandra-Petrescu F, Keese M, Rahbari NN, Reißfelder C, Rückert F. [Definition and treatment of superior mesenteric artery revascularization and dissection-associated diarrhea (SMARD syndrome) in Germany]. Chirurg 2021. [PMID: 34100984 DOI: 10.1007/s00104-021-01427-4] [Reference Citation Analysis]
6 Shaw K, Thomas AS, Rosario VL, Sugahara KN, Schrope BA, Chabot JA, Genkinger JM, Kwon W, Kluger MD. Long-term quality of life and global health following pancreatic surgery for benign and malignant pathologies. Surgery 2021;170:917-24. [PMID: 33892953 DOI: 10.1016/j.surg.2021.03.023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Oh MY, Kim EJ, Kim H, Byun Y, Han Y, Choi YJ, Kang JS, Kwon W, Jang JY. Changes in postoperative long-term nutritional status and quality of life after total pancreatectomy. Ann Surg Treat Res 2021;100:200-8. [PMID: 33854989 DOI: 10.4174/astr.2021.100.4.200] [Reference Citation Analysis]
8 Petrucciani N, Nigri G, Giannini G, Sborlini E, Antolino L, de'Angelis N, Gavriilidis P, Valente R, Lainas P, Dagher I, Debs T, Ramacciato G. Total Pancreatectomy for Pancreatic Carcinoma: When, Why, and What Are the Outcomes? Results of a Systematic Review. Pancreas 2020;49:175-80. [PMID: 32011524 DOI: 10.1097/MPA.0000000000001474] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
9 Shaw K, Thomas AS, Rosario V, Kwon W, Schrope BA, Sugahara K, Chabot JA, Genkinger JM, Kluger MD. Long term quality of life amongst pancreatectomy patients with diabetes mellitus. Pancreatology 2021;21:501-8. [PMID: 33509685 DOI: 10.1016/j.pan.2021.01.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Bayram O, Michalski CW, Kleeff J. Total Pancreatectomy. Textbook of Pancreatic Cancer 2021. [DOI: 10.1007/978-3-030-53786-9_61] [Reference Citation Analysis]
11 You L, Yao L, Mao YS, Zou CF, Jin C, Fu DL. Partial pancreatic tail preserving subtotal pancreatectomy for pancreatic cancer: Improving glycemic control and quality of life without compromising oncological outcomes. World J Gastrointest Surg 2020; 12(12): 491-506 [PMID: 33437401 DOI: 10.4240/wjgs.v12.i12.491] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Scholten L, Latenstein AE, Aalfs CM, Bruno MJ, Busch OR, Bonsing BA, Koerkamp BG, Molenaar IQ, Ubbink DT, van Hooft JE, Fockens P, Glas J, DeVries JH, Besselink MG; Dutch Pancreatic Cancer Group. Prophylactic total pancreatectomy in individuals at high risk of pancreatic ductal adenocarcinoma (PROPAN): systematic review and shared decision-making programme using decision tables. United European Gastroenterol J 2020;8:865-77. [PMID: 32703081 DOI: 10.1177/2050640620945534] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
13 Stuart CM, Lundgren MP, Lavu H, Yeo CJ. Pylorus-Preserving Total Pancreatectomy for Intraductal Papillary Mucinous Neoplasm in the Setting of Previous Roux-en-Y Cystjejunostomy for Pancreatic Pseudocyst. J Pancreat Cancer 2020;6:1-4. [PMID: 32043065 DOI: 10.1089/pancan.2019.0015] [Reference Citation Analysis]
14 Wu X, Liu Y. Total Pancreatectomy. Surgical Atlas of Pancreatic Cancer 2020. [DOI: 10.1007/978-981-32-9864-4_10] [Reference Citation Analysis]
15 Maeda S, Ariake K, Iseki M, Ohtsuka H, Mizuma M, Nakagawa K, Morikawa T, Hayashi H, Motoi F, Kamei T, Naitoh T, Unno M. Prognostic indicators in pancreatic cancer patients undergoing total pancreatectomy. Surg Today 2020;50:490-8. [PMID: 31768656 DOI: 10.1007/s00595-019-01924-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
16 Stoop TF, Ateeb Z, Ghorbani P, Scholten L, Arnelo U, Besselink MG, Del Chiaro M. Impact of Endocrine and Exocrine Insufficiency on Quality of Life After Total Pancreatectomy. Ann Surg Oncol 2020;27:587-96. [DOI: 10.1245/s10434-019-07853-3] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 8.3] [Reference Citation Analysis]
17 Scholten L, Stoop TF, Del Chiaro M, Busch OR, van Eijck C, Molenaar IQ, de Vries JH, Besselink MG; Dutch Pancreatic Cancer Group. Systematic review of functional outcome and quality of life after total pancreatectomy. Br J Surg 2019;106:1735-46. [PMID: 31502658 DOI: 10.1002/bjs.11296] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 12.0] [Reference Citation Analysis]
18 Scholten L, Latenstein AE, van Eijck C, Erdmann J, van der Harst E, Mieog JSD, Molenaar IQ, van Santvoort HC, Devries JH, Besselink MG, van Hooft JE, Bonsing BA, Bosscha K, Coene PL, van Dam RM, van Dieren S, Gerhards MF, van Goor H, de Hingh IH, Kazemier G, Klaase JM, Patijn GA, Scheepers JJ, van der Schelling GP, Pranger BK, Busch O, Snoek F. Outcome and long-term quality of life after total pancreatectomy (PANORAMA): a nationwide cohort study. Surgery 2019;166:1017-26. [DOI: 10.1016/j.surg.2019.07.025] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 8.0] [Reference Citation Analysis]
19 Pulvirenti A, Pea A, Rezaee N, Gasparini C, Malleo G, Weiss MJ, Cameron JL, Wolfgang CL, He J, Salvia R. Perioperative outcomes and long-term quality of life after total pancreatectomy. Br J Surg. 2019;. [PMID: 31282569 DOI: 10.1002/bjs.11185] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 12.3] [Reference Citation Analysis]
20 Yang DJ, Xiong JJ, Liu XT, Li J, Dhanushka Layanthi Siriwardena KM, Hu WM. Total pancreatectomy compared with pancreaticoduodenectomy: a systematic review and meta-analysis. Cancer Manag Res 2019;11:3899-908. [PMID: 31123419 DOI: 10.2147/CMAR.S195726] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
21 Scholten L, van Huijgevoort NC, Bruno MJ, Fernandez–del Castillo C, Satoi S, Sauvanet A, Wolfgang C, Fockens P, Chari ST, Del Chiaro M, van Hooft JE, Besselink MG. Surgical management of intraductal papillary mucinous neoplasm with main duct involvement: an international expert survey and case-vignette study. Surgery 2018;164:17-23. [DOI: 10.1016/j.surg.2018.01.025] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
22 Struyvenberg MR, Fong ZV, Martin CR, Tseng JF, Clancy TE, Fernández-Del Castillo C, Tillman HJ, Bellin MD, Freedman SD. Impact of Treatments on Diabetic Control and Gastrointestinal Symptoms After Total Pancreatectomy. Pancreas 2017;46:1188-95. [PMID: 28902790 DOI: 10.1097/MPA.0000000000000917] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
23 Hirono S, Yamaue H. Total Pancreatectomy. The Pancreas 2018. [DOI: 10.1002/9781119188421.ch106] [Reference Citation Analysis]
24 Wu W, Dodson R, Makary MA, Weiss MJ, Hirose K, Cameron JL, Ahuja N, Pawlik TM, Wolfgang CL, He J. A Contemporary Evaluation of the Cause of Death and Long-Term Quality of Life After Total Pancreatectomy. World J Surg. 2016;40:2513-2518. [PMID: 27177647 DOI: 10.1007/s00268-016-3552-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
25 Wang X, Tan CL, Song HY, Yao Q, Liu XB. Duodenum and ventral pancreas preserving subtotal pancreatectomy for low-grade malignant neoplasms of the pancreas: An alternative procedure to total pancreatectomy for low-grade pancreatic neoplasms. World J Gastroenterol 2017; 23(35): 6457-6466 [PMID: 29085195 DOI: 10.3748/wjg.v23.i35.6457] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
26 Maker AV, Sheikh R, Bhagia V; Diabetes Control and Complications Trial (DCCT) Research Group. Perioperative management of endocrine insufficiency after total pancreatectomy for neoplasia. Langenbecks Arch Surg 2017;402:873-83. [PMID: 28733926 DOI: 10.1007/s00423-017-1603-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
27 Li BQ, Liu QF, Chang XY, Hu Y, Chen J, Guo JC. Pancreatic carcinosarcoma mimics malignant intraductal papillary mucinous neoplasm: A rare case report and literature review. Medicine (Baltimore). 2017;96:e6961. [PMID: 28591030 DOI: 10.1097/md.0000000000006961] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
28 Wang X, Li Y, Cai Y, Liu X, Peng B. Laparoscopic total pancreatectomy: Case report and literature review. Medicine (Baltimore) 2017;96:e5869. [PMID: 28099344 DOI: 10.1097/MD.0000000000005869] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
29 Groot VP, van Santvoort HC, Rombouts SJ, Hagendoorn J, Borel Rinkes IH, van Vulpen M, Herman JM, Wolfgang CL, Besselink MG, Molenaar IQ. Systematic review on the treatment of isolated local recurrence of pancreatic cancer after surgery; re-resection, chemoradiotherapy and SBRT. HPB 2017;19:83-92. [DOI: 10.1016/j.hpb.2016.11.001] [Cited by in Crossref: 53] [Cited by in F6Publishing: 44] [Article Influence: 10.6] [Reference Citation Analysis]
30 Solomon SB, Griffin JF, Weiss MJ, Boas FE. Postoperative complications requiring intervention. Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2-Volume Set 2017. [DOI: 10.1016/b978-0-323-34062-5.00027-3] [Reference Citation Analysis]
31 Watanabe Y, Nishihara K, Matsumoto S, Okayama T, Abe Y, Nakano T. Effect of postoperative major complications on prognosis after pancreatectomy for pancreatic cancer: a retrospective review. Surg Today 2017;47:555-67. [DOI: 10.1007/s00595-016-1426-1] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
32 Del Chiaro M, Rangelova E, Segersvärd R, Arnelo U. Are there still indications for total pancreatectomy? Updates Surg 2016;68:257-63. [PMID: 27605208 DOI: 10.1007/s13304-016-0388-6] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 6.5] [Reference Citation Analysis]
33 Suzuki S, Miura J, Shimizu K, Tokushige K, Uchigata Y, Yamamoto M. Clinicophysiological outcomes after total pancreatectomy. Scandinavian Journal of Gastroenterology 2016;51:1526-31. [DOI: 10.1080/00365521.2016.1211173] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
34 Casadei R, Ricci C, Taffurelli G, Guariniello A, Di Gioia A, Di Marco M, Pagano N, Serra C, Calculli L, Santini D, Minni F. Is total pancreatectomy as feasible, safe, efficacious, and cost-effective as pancreaticoduodenectomy? A single center, prospective, observational study. J Gastrointest Surg 2016;20:1595-607. [DOI: 10.1007/s11605-016-3201-4] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 3.8] [Reference Citation Analysis]
35 Ishida J, Toyama H, Matsumoto I, Asari S, Goto T, Terai S, Nanno Y, Yamashita A, Mizumoto T, Ueda Y, Kido M, Ajiki T, Fukumoto T, Ku Y. Second primary pancreatic ductal carcinoma in the remnant pancreas after pancreatectomy for pancreatic ductal carcinoma: High cumulative incidence rates at 5 years after pancreatectomy. Pancreatology 2016;16:615-20. [DOI: 10.1016/j.pan.2016.05.003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
36 Joergensen MT, Gerdes AM, Sorensen J, Schaffalitzky de Muckadell O, Mortensen MB. Is screening for pancreatic cancer in high-risk groups cost-effective? - Experience from a Danish national screening program. Pancreatology 2016;16:584-92. [PMID: 27090585 DOI: 10.1016/j.pan.2016.03.013] [Cited by in Crossref: 37] [Cited by in F6Publishing: 27] [Article Influence: 6.2] [Reference Citation Analysis]
37 Higashihara T, Yoshitomi H, Shimizu H, Ohtsuka M, Kato A, Furukawa K, Miyazaki M. Four Cases of Middle Segment-preserving Pancreatectomy. Jpn J Gastroenterol Surg, Nihon Shokaki Geka Gakkai zasshi 2016;49:439-446. [DOI: 10.5833/jjgs.2015.0112] [Reference Citation Analysis]
38 Rezaee N, Barbon C, Zaki A, He J, Salman B, Hruban RH, Cameron JL, Herman JM, Ahuja N, Lennon AM, Weiss MJ, Wood LD, Wolfgang CL. Intraductal papillary mucinous neoplasm (IPMN) with high-grade dysplasia is a risk factor for the subsequent development of pancreatic ductal adenocarcinoma. HPB (Oxford). 2016;18:236-246. [PMID: 27017163 DOI: 10.1016/j.hpb.2015.10.010] [Cited by in Crossref: 62] [Cited by in F6Publishing: 65] [Article Influence: 8.9] [Reference Citation Analysis]